|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
NIMH
|
The Foundation for the National Institutes of Health (FNIH), together with National Institute of Mental Health (NIMH) and public and private partners, is leading the Accelerating Medicines Partnership - Schizophrenia (AMP; SCZ) as the first neuropsychiatric project within the AMP program. The public-private partnership will tackle the critical need for more effective treatments for people with schizophrenia.
|
|
AccessGUDID
|
Resource Development
|
FDA, GDM
|
NLM
|
The Global Unique Device Identification Database (GUDID) contains key device identification information submitted to the Food and Drug Administration (FDA) about medical devices that have Unique Device Identifiers (UDI). The National Library of Medicine (NLM), in collaboration with the FDA, has created the AccessGUDID portal to make device identification information in the GUDID available for everyone, including patients, caregivers, healthcare providers, hospitals, and industry.
|
|
ACL Advisory Council on Grandparents Raising Grandchildren
|
Committee, Work group, Advisory group, or Task Force
|
ACL, ACF, SAMHSA, CDC, HRSA, ASPE, ONC
|
NIA
|
The mission of the Advisory Council to Support Grandparents Raising Grandchildren (SGRG) is to identify, promote, coordinate and disseminate information, resources, and best practices to help grandparents and older relative caregivers of children meet the health, educational, nutritional, and other needs of the children in their care, while maintaining their own physical, mental, and emotional well-being. As part of this vision, all recommendations will consider the needs of members of Native American tribes and families affected by the opioid crisis.
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
NEI
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
Adaptive Optics Retinal Imaging
|
|
Adjuvant Working Group
|
Committee, Work group, Advisory group, or Task Force
|
BARDA, FDA, ASPR
|
NIAID, NCI
|
Staff from all National Institute of Allergy and Infectious Diseases (NIAID) Divisions, program staff from the Biomedical Advanced Research and Development Authority (BARDA), and regulatory staff from the Food and Drug Administration (FDA) exchange information about ongoing programs related to novel adjuvants for infectious disease vaccines, identify high priority research areas (and gap areas), and discuss ideas to accelerate progress in adjuvant research through better access to information and resources.
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NIDA, NCI, NIAAA, NICHD, NIMH, NIMHD, NINDS, OD/DPCPSI/OBSSR
|
The Adolescent Brain Cognitive Development (ABCD) project, a landmark longitudinal study of brain development and child health, will increase our understanding of how diverse experiences during adolescence interact with changing biology to influence brain, cognitive, and social/emotional development of youth. In partnership with area public and private schools, researchers at twenty-one research sites across the country will recruit 10,000 children at age 9-10 from diverse races and ethnicities, education and income levels, and living environments and follow them through their teens and into early adulthood. Throughout this period, researchers will assess each child’s physical and mental health, substance use, sleep patterns, genetics, childhood experiences, and cultural/environmental influences, as well as track brain and cognitive development with non-invasive magnetic resonance imaging scans at regular intervals. To enrich the value of the study, ABCD will release anonymized data annually to the research community in an open science model to allow scientists from all over the world to conduct analyses and pool resources to rapidly expand the types of scientific questions that can be answered. The actionable information coming out of this study will enable education, substance use prevention, and other health promotion policies to ensure the wellbeing and success of the Nation’s children.
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
NICHD, FIC, NIAID, NIMH, OD/DPCPSI/OAR
|
The Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA) aims to enhance the effective use of evidence and help overcome implementation challenges related to prevention, screening and treatment of HIV among adolescents (ages 15 to 24) in sub-Saharan Africa by catalyzing collaboration and communication among implementation scientists, program implementers and policymakers. The Center for Global Health Studies at Fogarty is launching the initiative in collaboration with the Office of the Global AIDS Coordinator and other NIH Institutes and Centers.
|
|
Adolescent Human Immunodeficiency Virus (HIV) Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/DPCPSI/OAR
|
The Adolescent Human Immunodeficiency Virus(HIV) Prevention and Treatment Implementation Science Alliance (AHISA) aims to enhance the effective use of evidence and help overcome implementation challenges related to prevention, screening, and treatment of HIV among adolescents (ages 15 to 24) in sub-Saharan Africa by catalyzing collaboration and communication among implementation scientists, program implementers, and policymakers. The goals of the Alliance are to: 1) provide a platform for cross-fertilization and exchange of ideas and information among implementation scientists and other stakeholders focusing on different aspects of HIV in adolescents; 2) enable the research to be better informed by programmatic challenges and questions; 3) inform policymakers of promising evidence and encourage use of the data in decision making; and 4) extend the reach and impact of implementation science related to adolescent HIV prevention and treatment.
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
NINDS
|
The Advanced Anticonvulsant System Interagency Product Team is a Department of Defense-led effort to facilitate activities, both research and regulatory, related to the FDA approval of midazolam for use in treating nerve agent exposure.
|